GPX4 and cancer: More recent studies indicate that the GPX4‐mediated antiferroptosis effect can be suppressed by tripartite motif 36 (TRIM36) [135], low‐dose antimony treatment [136], or AR inhibition [137], which reverses the NET process and has demonstrated effectiveness in treating cancers.